NDC 57894-111

CARVYKTI

Ciltacabtagene Autoleucel

CARVYKTI is a Intravenous Injection, Suspension in the Cellular Therapy category. It is labeled and distributed by Janssen Biotech, Inc. The primary component is Ciltacabtagene Autoleucel.

• Product ID: 57894-111_63fd4e9a-df60-487a-b810-fc20af8c924a
• NDC: 57894-111
• Product Type: Cellular Therapy
• Proprietary Name: CARVYKTI
• Generic Name: Ciltacabtagene Autoleucel
• Dosage Form: Injection, Suspension
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-02-28
• Marketing Category: BLA /
• Application Number: BLA125746
• Labeler Name: Janssen Biotech, Inc
• Substance Name: CILTACABTAGENE AUTOLEUCEL
• Active Ingredient Strength: 100000000 1/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 57894-111-01

1 INJECTION, SUSPENSION in 1 BAG (57894-111-01)

• Marketing Start Date: 2022-02-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details